Winton Group LTD Assembly Biosciences, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$19.05 - $36.45 $152,095 - $291,016	-7,984 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$34.41 - $44.23 $86,919 - $111,724	-2,526 Reduced 24.03%	7,984 $0
Q2 2018 Aug 20, 2018	SELL	$39.21 - $50.29 $178,052 - $228,366	-4,541 Reduced 30.17%	10,510 $0
Q1 2018 May 21, 2018	BUY	$41.7 - $64.16 $627,626 - $965,672	15,051 New	15,051 $0

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.